4DMedical wins contract to supply lung imaging technology to US radiology company
Posted: 17 December 2024 4DMedical (ASX: 4DX) has been awarded a contract with US-based Imaging Partners of Orange County (IPOC) to provide computed tomography (CT) scans for lung ventilation (LVAS) and lung density (LDAf) analysis. The contract – the…
Weaponising exosomes for breast cancer treatment
Posted: 17 December 2024 INOVIQ Limited (ASX:IIQ or INOVIQ) is pleased to announce that it has successfully completed stage 1 of its development program for an exosome therapeutic for breast cancer. In this in vitro proof-ofconcept (POC) study,…
Immutep Reports Promising New Data in Head and Neck Cancer at ESMO Immuno-Oncology 2024
Posted: 16 December 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive clinical results from Cohort B of the TACTI-003…
BioMelbourne Network and AusBiotech welcome the Victorian Government’s Economic Growth Statement
Posted: 12 December 2024 BioMelbourne Network, Victoria’s leading industry association for organisations engaged in biotechnology, medical technology, and health innovation in Victoria and AusBiotech, Australia’s leading national industry association representing more than 3000 members across the life…
Positive new data and strong recruitment in pancreatic cancer trial
Posted: 11 December 2024 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to report updated data from Company’s ongoing Phase 2a clinical trial. This trial is investigating the Company’s FAK inhibitor narmafotinib in combination with…
Ghana becomes first river blindness-endemic country to approve moxidectin
Posted: 10 December 2024 Medicines Development for Global Health (MDGH) announced today that the Ghana Food and Drugs Authority (FDA) has approved the marketing authorisation application for moxidectin 2 mg oral tablets for the treatment of river blindness (onchocerciasis)…
University of Melbourne and Colossal expand partnership with gift to support avian conservation
Posted: 10 December 2024 A US$1.5 million gift from the Colossal Foundation, a non-profit organisation established by Colossal Biosciences, will help researchers in the Faculty of Science develop new approaches to the conservation of bird species in Australia and…
Breakthrough Victoria invests in game changing aged care technology
Posted: 10 December 2024 Breakthrough Victoria is investing $2 million in Umps Health, a Victorian company developing sensors and AI to enable proactive aged care at home. The Umps Link, a smart home platform, is the product of…
Australian researchers win the ‘Nobel’ of high-performance computing
Posted: 10 December 2024 An Australian research team and their American collaborators have been awarded the 2024 Gordon Bell Prize, regarded as the ‘Nobel Prize’ of high-performance computing (HPC). University of Melbourne Associate Professor Giuseppe Barca and his team were named the winners…
University of Melbourne and Peter MacCallum Cancer Centre leading genomics-driven cancer prevention
Posted: 10 December 2024 Genomics-driven cancer prevention, testing and treatment strategies will be at the forefront of a new joint venture between the University of Melbourne and Peter MacCallum Cancer Centre (Peter Mac), announced in Melbourne today. The…
High blood pressure and shorter sleep may worsen brain decline: study
Posted: 10 December 2024 People with high blood pressure who also lack sleep may be at increased risk of reduced cognitive performance and greater brain injury, Monash University research has found. Published in the Journal of the American Heart…
World Leading Moderna Vaccine Facility Opens In Victoria
Posted: 10 December 2024 The Southern Hemisphere’s only mRNA manufacturing facility has opened in Victoria – backed by the Albanese and Allan Labor Governments – ensuring world-class mRNA vaccines and medicines can be made in Australia and creating…
